non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer#474777ClinicalTrials.gov
• Metabolomic Analysis of Lung Cancer#825679ClinicalTrials.gov
• Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer#311135ClinicalTrials.gov
• A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer#426769ClinicalTrials.gov
• Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer#830382ClinicalTrials.gov
• Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer#840001ClinicalTrials.gov
• Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer#143570ClinicalTrials.gov
• S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer#837240ClinicalTrials.gov
• Positron Emission Tomography for Detecting Non-small Cell Lung Cancer#826743ClinicalTrials.gov
• Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer#838975ClinicalTrials.gov
• Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery#28559ClinicalTrials.gov
• Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#832142ClinicalTrials.gov
• S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer#837263ClinicalTrials.gov
• Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer#813462ClinicalTrials.gov
• Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC#405145ClinicalTrials.gov
• Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)#311125ClinicalTrials.gov
• Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation#838054ClinicalTrials.gov
• Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer#805361ClinicalTrials.gov
• Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer#811306ClinicalTrials.gov
• DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer#831733ClinicalTrials.gov
• C-TIL051 in Non-Small Cell Lung Cancer#429756ClinicalTrials.gov
• Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer#123464ClinicalTrials.gov
• Gene Mutations in Non-Small Cell Lung Cancer Cells#810804ClinicalTrials.gov
• CISH Inactivated TILs in the Treatment of NSCLC#628523ClinicalTrials.gov
• Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)#829687ClinicalTrials.gov
• MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer#162482ClinicalTrials.gov
• Genomic Landscape of Ceritinib#813823ClinicalTrials.gov
• Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients#18603ClinicalTrials.gov
• Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients#217020ClinicalTrials.gov
• Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#840125ClinicalTrials.gov
• A Biomarker Screening Protocol for Participants With Solid Tumors#184830ClinicalTrials.gov
• Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer#290984ClinicalTrials.gov
• Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#801048ClinicalTrials.gov
• Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients#834320ClinicalTrials.gov
• Study of Salirasib to Treat Non-Small Cell Lung Cancer#835040ClinicalTrials.gov
• Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer#18606ClinicalTrials.gov
• Personalized DC Vaccines in Non Small Cell Lung Cancer#405221ClinicalTrials.gov
• Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)#481769ClinicalTrials.gov
• Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer#825481ClinicalTrials.gov
• SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects#474781ClinicalTrials.gov
• MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer#195332ClinicalTrials.gov
• AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer#141096ClinicalTrials.gov
• DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTS#245497ClinicalTrials.gov
• TF2- Small Cell Lung Cancer Radio Immunotherapy#353280ClinicalTrials.gov
• Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer#417558ClinicalTrials.gov
• Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma#377405ClinicalTrials.gov
• NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma#802981ClinicalTrials.gov
• Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer#146435ClinicalTrials.gov
• Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#839762ClinicalTrials.gov
• Study of Tarceva and Targretin in Stage I-II Lung Cancer#830406ClinicalTrials.gov

Related topics